Loading...
Symbols:
Loading...
Symbols:
Johnson & Johnson (JNJ)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Johnson & Johnson (JNJ)
424 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on JNJ
- SA Editor Miriam Metzinger(63)
- Bespoke Investment Group(31)
- SA Editor Eli Hoffmann(29)
- SA Editor Joan Wickham(28)
- Geoff Considine(15)
Most popular authors
(tracked in watchlists)
- Philip Davis(599)
- Bespoke Investment Group(575)
- Trader Mark(490)
- Bill Cara(432)
- SA Editor Eli Hoffmann(387)
Most commented on authors
- Bespoke Investment Group(133)
- SA Editor Joan Wickham(89)
- Geoff Considine(81)
- SA Editor Eli Hoffmann(69)
- Dividends4Life (65)
- AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA
- Nine Pharma Predictions for 2009
- Dividend Aristocrats Outperform in November
- Six High Quality Dividend Stocks
- Three-Month, Updated FDA Decision Calendar
- Dividends: There's No Such Thing as a Free Lunch on Wall Street
- Johnson & Johnson Is the Latest FDA Casualty
- Sell Risk, Buy Pharma
- Strategically Managing Your Dividend Portfolio During a Downturn
- Wall Street Breakfast: Must-Know News
- Profiting from Risk Aversion
- JNJ / Omrix: Potential Synergies
- NYSE Listings with Market Caps Greater Than $100B
- Stocks Will Continue to Erode In This Busted Economy
- The Dow's Lost Decade
- 73 Decision Dates on Updated FDA Calendar
- Investing in Stocks: Emotional vs. Financial Costs
- Dow Member Changes Since the 10/02 Low
- Regenerative Medicine: Big Pharma's Next Frontier
- Measuring Risk of a Dividends Investment Profile
- Ultra Brite Outlook for Colgate - Barron's
- Is Buy-and-Hold Dead? Hardly
- Thoughts on Market Volatility
- General Electric Moves On Down the Largest Company List
- Fast Money Recap - Will Goldman Be Tarnished? (11/10/08)
- S&P 500 Dividend Aristocrats and Your Portfolio
- Perception: Top Socially Responsible Companies Include Google, Campbell, J&J
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Parsing the Dismal October Employment Report
- ETFI Global Healthcare Sector PerfomIdex
- Dow Price Targets
- A Buy & Hold Forever Dividend Stock Portfolio
- Reality Check on the Big Pharma Rumor Mill
- Johnson & Johnson: Still Adding to My Position
- JP Morgan Analyst: Johnson & Johnson Not Worth the Sum of Its Parts
- Abundant Opportunities in Bear Markets
- 60 Defensive Growth Stocks
- Unfairly Punished - Fast Money Recap (10/24/08)
- Going Cautiously Long
- Bargains Abound in Four Large-Cap Leaders
- Big Pharma Feels Free Market Pain
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
1 new today)